Nothing has changed underneath
Issue: No measurable vision improvement after 3 months Potential causes: Unrealistic expectations (expecting improvement vs slowed decline), advanced disease with minimal salvageable tissue, inadequate dosing or inconsistent use, wrong peptide for specific condition, peptides genuinely ineffective for individual, progression monitoring inadequate missing subtle benefits
10.1371/journal.pone.0045166 40 DhabharF
in animal models of diabetes, P5P administration inhibited AGE formation, protein loss in the urine, fibrosis of kidney tissue, and development of diabetic kidney disease (Nakamura 2007)
However, chronic GH treatment carries substantial risks, including glucose intolerance, insulin resistance, diabetes, cancer, and cardiovascular complications